• What We Do
  • Who We Are
  • Simulations
  • Presentations & Research
  • Contact Us
  • White Paper
  • Disclaimer
  • Industry Sector
  • Global Region
  • ETF's and Futures
  • Major Funds - Holding
  • Tutorial
  • Best Risk Adjusted
  • Worst Risk Adjusted
  • Best Expected
  • Worst Expected
  • Sector Ranking
  • Dividend
  • REIT's
  • Leverage Risk
  • Convertible Bonds
  • Investment Grade
  • High Yield
  • ADR
  • Small Caps
Rational Investing
  • About Usarrow_drop_down
  • Coveragearrow_drop_down
  • Returnsarrow_drop_down
  • Productarrow_drop_down


Diagnostic Substances

       Total Market Capitalization of All Firms $106,354 mm             
       Average Market Capitalization $17,726 mm       
       Average Market to Model Ratio Weighted by Log of Market Cap 1.0       
       Standard Deviation of MM Ratio 0.3       
       Average Beta 0.9       
       Average EV To Revenue 8.3       
       Average EV To EBITDAM 27.8       
       Average Price To Free Cash Flow 46.4       

TickerCompany NameMarket To ModelMarket Cap ($ mm)EV to RevenuePrice To FCFEV/EBITDAM% GrowthBetaAs Of
NEOGNeogen Corp.1.574,46210.060.147.570.7Nov 20
QDELQuidel Corp.1.099,10012.034.224.1431.0Sep 20
IDXXIdexx Laboratories Inc.0.9943,04615.791.430160.9Sep 20
ICLRIcon Plc0.9511,7624.344.427.110.9Sep 20
IQVIQVIA Holdings Inc0.6737,0204.229.122.841.3Sep 20
VIVOMeridian Bioscience Inc.0.509633.619.015.4130.7Sep 20
Standard Value | About us | Contact us     Copyright © 2003-2021 Rational Investing LLC ® | All Rights Reserved